Article Information
- Received September 22, 2020
- Revision received December 2, 2020
- Accepted December 18, 2020
- Published online March 19, 2021.
Author Information
- Syed Faraz Kazim1,
- Joon Ho Seo1,
- Riccardo Bianchi2,
- Chloe S. Larson1,
- Abhijeet Sharma1,
- Robert K. S. Wong2,
- Kirill Y. Gorbachev1 and
- Ana C. Pereira1,3
- 1Department of Neurology and Nash Family Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029
- 2The Robert F. Furchgott Center for Neural and Behavioral Science, and Department of Physiology and Pharmacology, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY 11203
- 3Ronald M. Loeb Center for Alzheimer’s Disease, Icahn School of Medicine at Mount Sinai, New York, NY 10029
- Correspondence should be addressed to Ana C. Pereira at ana.pereira{at}mssm.edu.
Author contributions
Author contributions: S.F.K., J.H.S., R.B., C.S.L., A.S., R.K.S.W., K.Y.G., and A.C.P. wrote the paper.
Disclosures
The authors declare no competing financial interests.
A.C.P. is supported by National Institutes of Health Grants R01AG064020 and R01AG063819, the Paul B. Beeson Emerging Leaders Career Development Award in Aging K76AG054772, the BrightFocus Foundation, the DANA Foundation, the Alzheimer’s Drug Discovery Foundation, the Alzheimer’s Association, the Bernard L. Schwartz Award for Physician Scientist, and seed money from Icahn School of Medicine at Mount Sinai. S.F.K. was supported by a doctoral fellowship from Neural and Behavioral Science Program, School of Graduate Studies, State University of New York (SUNY) Downstate Medical Center and SUNY Downstate/New York State Institute for Basic Research (NYSIBR) Program in Developmental Neuroscience, when initial ideas related to the discussion and perspectives presented in manuscript were generated and a part of this review was written.
Funding
NIH
R01AG064020; R01AG063819Paul B. Beeson Emerging Leaders Career Development Award
K76AG054772The BrightFocus Foundation
The DANA Foundation
The Alzheimer's Drug Discovery Foundation
The Alzheimer's Association
The Bernard L. Schwartz Award for Physician Scientist
Seed money from Icahn School of Medicine at Mount Sinai
Other Version
- You are viewing the most recent version of this article.
- previous version (March 19, 2021).
Article usage
In this issue
Jump to section
- Article
- Abstract
- Significance Statement
- Introduction
- Aβ Induces Neuronal Network Hyperexcitability in AD, Even before the Development of Plaques
- The Role of tau in Neuronal Network Excitability: The Enhancement versus Suppression Conundrum
- Perspectives on the Similar versus Divergent Roles of Aβ and tau in Neuronal Network Hyperexcitability in AD: Which One Has a Dominant Effect, Aβ or tau?
- Future Directions and Concluding Remarks
- Acknowledgments
- Footnotes
- References
- Synthesis
- Figures & Data
- Info & Metrics
- eLetters